Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) Investor Alert: Kaplan Fox Investigates Potential Securities Fraud
October 31, 2022 10:13 ET
|
Kaplan Fox & Kilsheimer LLP
NEW YORK, Oct. 31, 2022 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors in Y-mAbs Therapeutics, Inc. (“Y-mAbs” or the...
RITE AID INVESTOR ALERT: Kaplan Fox & Kilshiemer LLP Notifies Rite Aid Investors of a Class Action Lawsuit and Upcoming Deadline
October 26, 2022 14:39 ET
|
Kaplan Fox & Kilsheimer LLP
NEW YORK, Oct. 26, 2022 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Rite Aid Corporation (“Rite Aid” or the "Company”)...